After losing his father to liver cancer, Ghanaian immunologist Yaw Bediako recognized the significant cancer burden in Africa, which causes about 700,000 deaths annually. He co-founded Yemaachi Biotech in 2020 to establish a database of genetic and clinical information from 7,500 cancer patients. This initiative aims to improve cancer research on the continent, addressing treatment disparities, especially among pediatric patients. With backing from Roche, the project seeks to offer free access to insights that will enhance drug discovery and support clinicians in Africa, where less than 2% of genomic data analyzed comes from African patients.
Yaw Bediako, an immunologist, founded Yemaachi Biotech to address the significant lack of cancer research in Africa, highlighting the continent's hidden cancer burden.
Cancer accounts for approximately 700,000 deaths annually in Africa, yet very few scientific papers focus on the disease or its impacts across the continent.
Bediako’s company aims to create a comprehensive database of genetic and clinical information from 7,500 African cancer patients, promoting better treatment and drug discovery.
Supported by Roche, the initiative will address disparities in cancer outcomes and provide invaluable insights into African populations, including data on pediatric cancers.
Collection
[
|
...
]